Clinical Trial Update: A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the usability of a subcutaneous auto-injector for CT-P47 in patients with active rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CT-P47 (tocilizumab biosimilar)

Snippet

Sponsor: Celltrion | Conditions: Rheumatoid Arthritis | Phase 3 | Status: UNKNOWN